SCHEMBL6883018

SCHEMBL6883018

CC(C)c1ccc(-c2ccc(C3CCCCC3)c(O)c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ EPHX1 P07099 2/20 0.38
▸ EPHX2 P34913 2/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ NFKB1 P19838 1/20 0.38
▸ NFKB2 Q00653 1/20 0.38
▸ RELA Q04206 1/20 0.38
▸ APP P05067 1/20 0.37
▸ PTGDR2 Q9Y5Y4 3/20 0.36
▸ PTGDR Q13258 2/20 0.36
▸ HSP90AA1 P07900 2/20 0.36
▸ NUDT1 P36639 1/20 0.36
▸ BACE1 P56817 1/20 0.36
▸ PTPN5 P54829 1/20 0.36
▸ TYR P14679 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16736898 0.85 TRPA1 (0.48) SMN1; SMN2HTTTP53HSP90AA1NUDT1
SCHEMBL2052453 0.79 TRPA1 (0.52) SMN1; SMN2LMNAHTTTP53NFKB1
SCHEMBL7076137 0.78 ABL1 (0.43) SMN1; SMN2NPC1RAB9ATP53APP
SCHEMBL11877058 0.78 NUDT1 (0.50) SMN1; SMN2EPHX1EPHX2NPSR1NPC1
SCHEMBL8712858 0.75 APP (0.37) APPBACE1PTPN5RXRARXRB
SCHEMBL20640289 0.73 TRPA1 (0.42) LMNAHSP90AA1NUDT1BACE1TYR
SCHEMBL17878526 0.73 APP (0.61) LMNAHTTNFKB1APPTYR
SCHEMBL918998 0.72 GAA (0.49) NPC1LMNAHTTRAB9ATP53
SCHEMBL9271805 0.72 KDM4E (0.42) SMN1; SMN2EPHX1EPHX2NPSR1NPC1
SCHEMBL6882613 0.72 ALOX5 (0.55) NPC1LMNAHTTRAB9AAPP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6753451-B2 REACTING KETO COMPOUND, 1,3-DIOXOLANE, AND AN AMMONIUM HALIDE TO YIELD A B-AMINOKETONE; REACTING WITH N-ACETYLMETHYLPYRIDINIUM HALIDE; FRIEDEL-CRAFTS ALKYLATION CIBA SPECIALTY CHEMICALS CORPORATION 2004-06-22 — — US disclosed
US-20030191349-A1 Process for the preparation of phenylphenol compounds CIBA SPECIALTY CHEMICALS CORP. 2003-10-09 — — US disclosed
EP-1313689-A1 PROCESS FOR THE PREPARATION OF PHENYLPHENOL COMPOUNDS Ciba SC Holding AG (CH) 2003-05-28 — — EP disclosed
WO-2002018311-A1 PROCESS FOR THE PREPARATION OF PHENYLPHENOL COMPOUNDS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2002-03-07 — — WO disclosed
US-5723500-A WATER INSOLUBLE, NONCATIONIC, ANTIBACTERIAL, STERICALLY HINDERED PHENOL; MOUTHWASHES, DENTIFRICES COLGATE-PALMOLIVE COMPANY (US) 1998-03-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030191349-A1 Process for the preparation of phenylphenol compounds PAH, CYP1A1, CYP2D6 SMN1; SMN2 4876/4885EPHX1 1804/4885EPHX2 2372/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback